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Abstract
Pathogens use numerous methods to subvert host immune responses, including the modulation of
host IL-10 production by diverse cell types. However, the B cell sources of IL-10 and their overall
influence on innate and cellular immune responses have not been well characterized during
infections. Using Listeria as a model pathogen, infection drove the acute expansion of a small
subset of regulatory B cells (B10 cells) that potently suppress inflammation and autoimmunity
through the production of IL-10. Unexpectedly, spleen bacteria loads were 92–97% lower in B10
cell-deficient CD19−/− mice, in mice depleted of mature B cells, and in mice treated with CD22
mAb to preferentially deplete B10 cells before infection. By contrast, the adoptive transfer of wild
type B10 cells reduced bacterial clearance by 38-fold in CD19−/− mice through IL-10-dependent
pathways. B10 cell depletion using CD22 mAb significantly enhanced macrophage phagocytosis
of Listeria and their production of IFN-γ, TNF-α, and nitric oxide ex vivo. Accelerated bacteria
clearance following B10 cell depletion significantly reduced Ag-specific CD4+ T cell proliferation
and cytokine production, but did not alter CD8+ T cell responses. B10 cell regulatory function
during innate immune responses was nonetheless dependent on cognate interactions with CD4+ T
cells since B10 cells deficient in IL-10, MHC-II or IL-21 receptor expression did not influence
Listeria clearance. Thus, Listeria manipulates immune responses through a strategy of immune
evasion that involves the preferential expansion of endogenous B10 cells that regulate the
magnitude and duration of both innate and cellular immune responses.
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INTRODUCTION
Infectious organisms use numerous methods to subvert host immune responses, including
the modulation of host cytokine production (1, 2). Listeria monocytogenes is a frequently
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used model for both infection and immune response evasion in mice (3). This facultative
Gram-positive bacterium also causes listeriosis in humans. Listeria typically replicates
within the cytosol of macrophages and epithelial cells, which protects the bacteria from
deletion during humoral immune responses. Listeria and several other pathogens also induce
serum IL-10 (4), a potent cytokine that can facilitate pathogen survival by negatively
regulating both innate and acquired host immune responses (5–9). Consequently, IL-10−/−
mice are resistant to infection with Listeria and other pathogens (7, 10, 11). Multiple cell
types are capable of producing IL-10, including activated macrophages, T and B
lymphocytes, mast cells, dendritic cells, and keratinocytes (5, 12, 13). How these distinct
IL-10 producing cell subsets individually dictate the quality, quantity, and direction of host
immune responses is generally unknown.
In addition to the classical immune responses that are induced during pathogen infections,
host immunoregulatory pathways may also become activated to limit the magnitude and
duration of immune responses and to prevent excessive immunopathology. B cell IL-10
production has been implicated in the negative regulation of immune responses against
bacteria, helminths and parasitic protozoa. B cell-derived IL-10 can suppress Salmonella
immunity by inhibiting neutrophils, natural killer cells, and inflammatory T cells (14). IL-10
produced by adoptively transferred peritoneal cavity B-1 cells also inhibits Borrelia hermsii
clearance in B cell-deficient mice (15). B cells from Brudia pahangi infected mice produce
IL-10, which down regulates B cell expression of the B7-1 and B7-2 costimulatory
molecules (16). Schistosoma mansoni infection also induces spleen IL-10-secreting B cells
in mice, which protects against allergic hypersensitivity (17, 18). B cells also produce IL-10
following Leishmania major infection, which can inhibit dendritic cell IL-12 production in
vitro (8). Despite these individual findings, the B cell sources of IL-10 have not been well
characterized in most cases and their overall influence on innate and cellular immune
responses during infections has not been examined.
A subset of immunoregulatory B cells has been functionally identified in mice and humans
by their ability to express IL-10 within 5 h of ex vivo stimulation (13, 19, 20). These rare
IL-10-competent B cells have been functionally labeled as “B10 cells” to distinguish them
from other regulatory B cell subsets that are known to exist (21, 22). Regulatory B10 cells
limit inflammation and disease in mouse models of contact hypersensitivity, experimental
autoimmune encephalomyelitis, lupus, allergy, and collagen-induced arthritis (20, 23–26).
Regulatory B10 cells are found in the spleens of naïve mice at low frequencies (1–5%),
where they predominantly represent a subset of the CD1dhiCD5+CD19hi B cell
subpopulation (13, 20, 27) that shares overlapping cell surface markers with multiple
phenotypically-defined B cell subsets (23, 28, 29). Agonistic CD40 signals or LPS can also
“mature” additional CD1dhiCD5+ B10 progenitor (B10pro) cells to acquire IL-10
competence (21, 30, 31). Cognate interactions between T cells and B10 cells induce Ag-
specific regulatory B10 effector cells that secrete Il-10 and regulate autoimmunity in vivo
(32). IL-10-competent regulatory B cells that parallel mouse B10pro and B10 cells have also
been identified in healthy and autoimmune humans (33). The capacity of human and mouse
B10pro and B10 cells to express IL-10 is central to their negative regulation of
inflammation, autoimmunity, and adaptive and innate immune responses (13, 20, 26, 30, 32,
34–36). B cell expression of cytoplasmic IL-10 protein parallels both their expression of
IL-10 transcripts and secretion of IL-10 as measured by ELISA (13, 20, 26, 30, 32, 34–36).
The current studies demonstrate that Listeria infection induces acute B10 cell expansion and
IL-10 production in mice, which inhibits macrophage activation. As a consequence, bacteria
loads are increased, thereby promoting T cell expansion and the development of cellular
immunity. Conversely, B10 cell-deficiency or depletion uniquely reshapes the course and
magnitude of both innate and cellular immune responses during infections.
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C57BL/6, Il-10−/− (B6.129P2-Il10tmlCgn/J), and Tiger (B6.129S6-Il10tm1Flv/J) mice (37)
were from The Jackson Laboratory (Bar Harbor, ME). A gene dose-dependent decrease in
IL-10 production was not observed in homozygous Tiger mice, which occurs with T cells
(37). MHC-II−/− (B6.129-H2-Ab1tm1GruB2mtmJaeN17) mice (38) were from Taconic Farms,
Inc. (Hudson, NY). CD19−/− mice (39) were backcrossed with C57BL/6 mice for 14
generations. CD22−/−CD154Tg mice (31) were homozygous at both genetic loci. OT-II
transgenic (Thy1.2+) mice (40) were crossed to Thy1.1+ mice to generate OT-II/Thy1.1-
expressing T cells. The OVA-specific TCR transgenic line (OT-I) was as described (41).
CD20−/−and IL-10−/−CD20−/− mice were as described (20). IL-21−/− mice were as described
(42). All mice were bred in a specific pathogen-free barrier facility and used at 8–12 wk of
age.
Total B cells were depleted in vivo using sterile, endotoxin-free CD20 mAb (MB20-11,
IgG2c) as described (43). B10 cells were depleted in vivo using sterile, endotoxin-free CD22
(MB22-10, IgG2c) mAb as described (26, 27). CD20, CD22 or isotype-matched control
mAb (250 μg in 200 μl PBS) were injected into the peritoneal cavity. All animal studies and
procedures were carried out in accordance with the recommendations in the Guide for the
Care and Use of Laboratory Animals of the National Institutes of Health and were approved
by the Duke University Institutional Animal Care and Use Committee.
Cell preparation and immunofluorescence analysis
Single-cell leukocyte suspensions from spleens and peripheral lymph nodes (pooled
bronchial, axillary, and inguinal) were generated by gentle dissection. For macrophage
assays, splenocytes were adhered to 6-well plates for 3 h. The plates were then washed twice
with sterile PBS. Adherent macrophages (>90% F4/80+CD11b+) were removed by scraping
and stimulated with LPS (1 μg/ml) for 4 or 24 h.
FITC-, PE-, PE Cy5-, PE Cy7-, or allophycocyanin (APC)-conjugated CD1d (1B1), CD4
(H129.19), CD8 (53-6.7), CD5 (53-7.3), CD11b (M1/70), CD11c (N418), CD19 (6D5),
F4/80 (BM8), CD49b (DX-5), CD80 (16-10A1), CD86 (GL1), Ly6C (AL21), Ly6G (1A8),
and Thy1.1 (HIS5.1) mAbs were from BD Biosciences (San Diego, CA). Intracellular
cytokine staining was performed using cytofix/cytoperm (BD Biosciences) with mAbs
reactive with IL-10 (JES5-16E3), IFN-γ (XMG1.2), and TNF-α (MP6-XT22) (from
eBioscience, San Diego, CA). Macrophages were identified by cell surface F4/80 and
CD11b expression. For two- to six-color immunofluorescence analysis, single-cell
suspensions (106 cells) were stained at 4°C using predetermined optimal concentrations of
mAb for 20 min as described (44). Background staining was assessed using nonreactive,
isotype-matched control mAbs (Caltag Laboratories, San Francisco, CA). Cells with the
forward and side light scatter properties of lymphocytes or macrophages were analyzed
using a BD FACSCanto II (BD Biosciences). Dead cells were detected using a LIVE/DEAD
Fixable Violet Dead Cell Stain Kit (Life Technologies) before cell surface staining. All flow
cytometry experiments were gated on viable, single lymphocytes or macrophages. For
macrophage intracellular cytokine staining, splenocytes were harvested 1 d following
infection and incubated with brefeldin A (1 μg/ml; eBioscience) for 5 h in the absence of
stimulation. For Ag-specific T cell intracellular cytokine staining, lymphocytes were
stimulated in vitro with OVA329-339 or OVA257-264 (10 μg/ml; American Peptide,
Sunnyvale, CA) in the presence of brefeldin A (1 μg/ml) for 5 h before staining.
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Intracellular IL-10 expression was visualized by immunofluorescence staining and analyzed
by flow cytometry as described (45). Briefly, isolated leukocytes or purified cells were
resuspended (2 × 106 cells/ml) in complete medium (RPMI 1640 media containing 10%
FCS, 200 μg/ml penicillin, 200 U/ml streptomycin, 4 mM L-glutamine, and 5 × 10−5 M 2-
ME, all from Life Technologies, Grand Island, NY) with LPS (10 μg/ml, Escherichia coli
serotype 0111:B4; Sigma-Aldrich), phorbol 12-myristate 13-acetate (50 ng/ml; Sigma-
Aldrich), ionomycin (500 ng/ml; Sigma-Aldrich, St. Louis, MO), and monensin (2 μM;
eBioscience) for 5 h in 48-well flat-bottom plates. In some experiments, the cells were
incubated for 48 h with an agonistic anti-mouse CD40 mAb (1 μg/ml; HM40-3; BD
Biosciences) as described (45). For IL-10 detection, Fc gamma receptors II and III were
blocked with mouse Fc receptor mAb (2.4G2; BD Biosciences), and dead cells were
identified using a LIVE/DEAD Fixable Violet Dead Cell Stain Kit (Life Technologies)
before cell surface molecule immunofluorescence staining. Cells stained for cell surface
molecules were fixed and permeabilized using a Cytofix/Cytoperm kit (BD Biosciences),
according to the manufacturer’s instructions, and stained with APC-conjugated anti-mouse
IL-10 mAb.
Infection, recovery and labeling of bacteria
Mice were infected i.v. with Listeria strain 10403S engineered to express chicken ovalbumin
(OVA; kindly provided by Dr. Hao Shen, University of Pennsylvania, Philadelphia, PA) (40,
46). For immunizations, bacteria were inoculated into brain heart infusion media
supplemented with erythromycin (5 μg/ml) overnight at 37°C. An aliquot (1 ml) of the
overnight bacteria culture was washed twice with sterile PBS and diluted in PBS for
infections as described (47). Mice received diluted bacteria (8 × 105 cfu, 0.1 LD50 in 200 μl)
through the lateral tail vein. The inoculum was subsequently serially diluted on brain heart
infusion plates and counted to verify the infection dose. At this infection dose, there are no
symptoms of weight loss or core body temperature changes.
To recover bacteria from infected mice, spleens were harvested and homogenized using a
Tissuemizer (Fischer Scientific, Pittsburgh, PA) in 4 ml of sterile PBS. The spleen
homogenates were serially diluted in sterile PBS 10-fold until a dilution of 105. A 100 μl
aliquot of each dilution was spread on brain heart infusion plates supplemented with
erythromycin (5 μg/ml) and incubated at 37°C for 24–48 h before the colonies were counted
to determine bacteria numbers.
Bacteria were labeled as previously described (48, 49). Briefly, bacteria were incubated with
100 μM CFSE (Invitrogen) for 10 minutes at 37°C, washed in PBS and immediately used
for the in vitro infection of macrophages. CFSE-labeling did not affect bacteria viability
(data not shown) as described (50). The number of phagocytosed bacteria was determined
using a similar protocol as that used for other Gram-positive bacteria. Briefly, macrophages
were infected at a multiplicity of infection of 10 for 2 h before the macrophages were
washed, harvested, and assessed for CFSE+ bacteria. Extracellular bacteria were eliminated
from the analysis by adding trypan blue (0.2% final) prior to flow cytometry analysis as
described (51).
Lymphocyte subset isolation and adoptive transfer experiments
Splenic B cells from naïve wild type, IL-10−/−, CD22−/−CD154Tg, CD20−/− or
CD20−/−IL-10−/− mice were isolated using CD19 mAb-coated microbeads (Miltenyi Biotec,
Auburn, CA) according to the manufacturer’s instructions. When necessary, B cells were
enriched a second time using a fresh magnetic-activated cell sorting column to obtain >95%
cell purities. CD1dhiCD5+ and CD1dloCD5− B cells were identified by immunofluorescence
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staining and purified (95–98%) using a FACSAria flow cytometer (BD Biosciences). B cell
subset isolation did not induce detectable IL-10 production (data not shown). After
purification, 106 cells were immediately transferred into appropriate recipient mice through
a lateral tail vein. Without appropriate ex vivo stimulation, the donor B cells remained IL-10
negative following transfers into recipient mice. Splenic CD4+ or CD8+ T cells, and
macrophages were purified using CD4+ T cell isolation kits, CD8+ T cell isolation kits, and
CD11b mAb-coated microbeads (Miltenyi Biotec), respectively. When necessary, the cells
were enriched a second time using a fresh magnetic-activated cell sorting column to obtain
>95% cell purities. Isolated CD4+ or CD8+ T cells from naïve OT-II/Thy1.1+ or OT-I mice
were labeled with CFSE (5 μM) for 10 min at 37°C, with 3×106 cells transferred i.v. into
recipient mice.
ELISAs
For assessing IFN-γ production, purified macrophages were stimulated in vitro with media
or LPS (1 μg/ml) for 4 or 24 h. Tissue culture supernatant fluid IFN-γ concentrations were
measured by ELISA (BD Biosciences) according to the manufacturer’s instructions. For
assessing IL-10 secretion, purified CD19+, CD1dhiCD5+, or CD1dloCD5− B cells (4 ×
105/0.2 ml of complete medium) from naïve or Listeria infected mice were cultured in
triplicate using 96-well flat-bottom tissue culture plates. Culture supernatant fluid IL-10
concentrations were quantified using IL-10 OptEIA ELISA kits (BD Pharmingen) following
the manufacturer’s protocols.
Statistical analyses
Differences between means were assessed using the Student’s t-test (GraphPad Prism
software, version 5.00, San Diego, CA). Significant differences between data sets that were
not normally distributed or were of unequal variance were determined using the Mann–
Whitney rank sum test. P values of <0.05 were considered significant.
RESULTS
B10 cells expand during L. monocytogenes infection
The effects of infection on spleen CD19+ B cells was assessed in wild type mice given L.
monocytogenes engineered to express chicken OVA (40, 46). Following 3 d of infection,
there was little change in spleen B cell or CD4+ T cell numbers relative to control mice
given PBS (Fig. 1A). B cell numbers increased significantly by day 5 along with a 46%
(p=0.03) reduction in CD4+ T cell frequencies, with normal cell numbers by 8 d post-
infection, as described (52). Listeria infection alone did not induce measurable IL-10
expression in B cells cultured ex vivo with monensin alone (Fig. 1B). Therefore, changes in
regulatory B10 cell frequencies and numbers during Listeria infection were assessed
following ex vivo B cell stimulation with PMA, ionomycin, and monensin (PIM) for 5 h to
induce cytoplasmic IL-10 accumulation that was visualized by immunofluorescence staining
with flow cytometry analysis as described (45). LPS was added to the 5 h PIM cultures
(LPIM) as it marginally enhances B10 cell enumeration (30). The advantage of using
cytoplasmic IL-10 expression to enumerate B10 cells is that this technique demonstrates the
frequency and numbers of B cells that are competent to express IL-10 and the level of IL-10
synthesis once induced.
Following Listeria infection, spleen B10 cell numbers dropped by day 3, but expanded 2-
fold by 5 d post-infection (p≤0.03) and remained elevated in the spleen and lymph nodes by
d 8 when compared with uninfected control mice. The spleen CD1dhiCD5+ B cell subset
was also significantly expanded by 5 d post-infection, while the CD1dloCD5+ B cell subset
did not increase significantly (Fig. 1C). When B10 cell numbers were quantified using Tiger
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IL-10/GFP reporter mice (37), similar results were obtained. Listeria infection of Tiger mice
did not induce detectable GFP expression, but GFP+ cell frequencies and numbers paralleled
B10 cell cytoplasmic IL-10 expression in wild type mice following LPIM stimulation (Fig.
1B and D). Thus, B10 cell numbers increased significantly following infection.
Agonistic CD40 signals induce B10pro cell maturation, which renders these cells competent
to express IL-10 following 5 h of LPIM stimulation (26, 30). Both B10 and B10pro cells
(B10+B10pro) are quantified in this assay, as the B cells that acquire IL-10 competence in
vitro (e.g., matured B10pro cells) cannot be differentiated from preexisting B10 cells that
express cytoplasmic IL-10 after 5 h of LPIM stimulation. Spleen B10+B10pro cell numbers
decreased by 87% (p=0.02) on d 3 post-infection, but returned to uninfected levels by 5–8 d
post-infection (Fig. 1E). Infection did not significantly affect lymph node B10+B10pro cell
numbers.
Listeria infection induced modest but measurable IL-10 secretion by purified spleen B cells
cultured ex vivo without stimulation (Fig. 1F). LPS stimulation in vitro induced significant
B cell IL-10 production, with more IL-10 produced by B cells isolated from Listeria-
infected mice. The CD1dhiCD5+ B cell subset was enriched 10-fold for IL-10-secreting B
cells relative to CD1dloCD5− B cells (Fig. 1G). Thus, Listeria infection was predominantly
activating a subset of B cells within the CD1dhiCD5+ B10+B10pro cell pool.
Spleen FoxP3+CD25+CD4+ regulatory T cell (Treg) frequencies or numbers were not
significantly changed following Listeria infection (d 5, Fig. 1H). However, the frequency
and number of activated CD4+ T cells (FoxP3−CD25+) increased by five-fold. Thus, the
B10 cell subset preferentially expanded following Listeria infection, while the B10pro and
Treg cell subsets did not.
B10 cells inhibit L. monocytogenes clearance
The impact of B cells and B10 cells on Listeria infection was assessed using three different
mouse models; CD19−/− mice, CD20 mAb-treated mice, and CD22 mAb-treated mice. Most
B cell subsets develop normally in CD19−/− mice (53), but they are deficient in B10 cells
(13, 26, 30, 32, 34, 35, 54, 55). Relative to wild type littermates, total spleen B cell numbers
were 32% (p=0.006) lower in uninfected and day 5 infected CD19−/− mice (Fig. 2A).
However, B10 cell numbers were reduced by 83% (p=0.001) in CD19−/− mice, and this did
not change with infection. CD20 mAb treatment depletes all mature B cells and B10 cells
(13, 20, 27, 56). Total B cell depletion by CD20 mAb reduced B10 cell and B cell numbers
by >97% (p<0.0001) in both control and Listeria-infected mice (Fig. 2B). CD22 mAb
treatment does not significantly reduce peripheral B cell numbers but depletes the majority
of spleen CD1dhiCD5+ B cells, which results in significant B10 cell reductions (26, 31, 57).
The term “depletion” as used in conjunction with CD20 and CD22 mAb treatments in this
study designates significant reductions in the frequencies and numbers of tissue lymphocytes
that either express a mature B cell phenotype (CD20 mAb), a CD1dhiCD5+ phenotype
(CD22 mAb), or that are able to express IL-10 (CD20 or CD22 mAb) as published (13, 20,
26, 27, 31, 56, 57). CD22 mAb treatment reduced CD1dhiCD5+ (B10 cell-enriched) cell
numbers by 60% (p=0.01) in uninfected mice and by 83% (p=0.003) in infected mice, but
did not significantly affect total B cell numbers (Fig. 2C). B10 cell numbers were reduced
by 80% (p=0.002) in uninfected mice and by 85% (p=0.03) in infected mice following
CD22 mAb treatment. In contrast with CD20 and CD22 mAb-treated mice, B10 cell
numbers increased 1.6-fold (p=0.02) in control mAb-treated mice by 5 d post-infection
when compared with uninfected littermates (Fig. 2B–C). Thus, CD19-deficiency, total B cell
depletion using CD20 mAb, and CD22 mAb treatment each significantly reduced B10 cell
numbers following infection.
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Spleen bacteria loads were reduced significantly (p≤0.01) by CD19-deficiency (97%), total
B cell depletion using CD20 mAb (92%), or CD22 mAb treatment (93%, notice different
scale on bar graph) as early as 3 d post-infection when compared with wild type or control
mAb-treated littermates (Fig. 2D). Spleen bacteria loads also remained 95% lower 5 d post-
infection in CD22 mAb-treated mice when compared with control mAb-treated littermates.
Similar results were obtained for liver bacteria loads (data not shown). Thus, CD19-
deficiency, total B cell depletion, and CD22 mAb treatment significantly accelerated Listeria
clearance in vivo.
Adoptive transfer experiments were used to verify that bacterial clearance was accelerated
due to the absence of regulatory B10 cells. Purified spleen CD1dhiCD5+ (B10 cell-enriched)
and CD1dloCD5− (B10 cell-deficient) B cell subsets from wild type mice were adoptively
transferred into B10 cell-deficient CD19−/− mice prior to Listeria infection (Fig. 2E). Spleen
bacteria loads were 38-fold higher in CD19−/− mice given CD1dhiCD5+ B cells in
comparison with littermates given PBS or CD1dloCD5− B cells 3 d post-infection (p=0.01).
CD1dhiCD5+ and CD1dloCD5− B cells from IL-10−/− mice were also transferred into
CD19−/− mice before infection. However, spleen bacteria levels were equivalent in mice that
received PBS, IL-10−/− CD1dhiCD5+ B cells, or IL-10−/− CD1dloCD5− B cells (3 d post-
infection; p=0.29). Thus, three independent mouse models where B cells or subsets of B
cells were depleted and adoptive transfer experiments demonstrated that B10 cells inhibited
Listeria clearance through IL-10-dependent mechanisms.
B10 cell depletion enhances macrophage cytokine production
The effect of B10 cell depletion on spleen macrophage and neutrophil numbers and
activation was assessed ex vivo 1 d after Listeria infection. In wild type mice, CD22 mAb
treatment did not significantly alter the frequencies or numbers of spleen CD11b+Ly6C+
macrophages or CD11b+Ly6G+ neutrophils (Fig. 3A). Similarly, CD22 mAb treatment did
not result in spleen F4/80+CD11b+ macrophage activation as measured by ex vivo CD80
and CD86 expression (Fig. 3B). However, CD22 mAb treatment significantly enhanced ex
vivo macrophage production of IFN-γ (2.6-fold, p=0.02) and TNF-α (40%, p=0.03) when
compared with macrophages from control mAb-treated mice (Fig. 3C). By contrast, CD22
mAb treatment did not significantly affect IFN-γ production by CD11c+ (dendritic) or
DX-5+ (natural killer) cells (data not shown). Thus, in vivo CD22 mAb treatment
significantly enhanced macrophage cytokine production.
Adoptive transfer experiments were carried out in parallel with the experiments described
above to verify that the absence of regulatory B10 cells following CD22 mAb treatment
enhanced infection-induced macrophage cytokine production. First, spleen CD1dhiCD5+ and
CD1dloCD5− B cells were purified from CD22−/−CD154Tg mice, in which the majority of
CD1dhi B cells are B10 cells (31). These B cell subsets were then adoptively transferred into
wild type mice that were given CD22 mAb prior to Listeria infection. Since the adoptively
transferred B cells are CD22-deficient, they are not affected by CD22 mAb treatment (57).
IFN-γ and TNF-α production by macrophages from CD22 mAb-treated mice (Fig. 3C)
were reduced by 67% and 54% (p=0.01), respectively, by the adoptive transfer of
CD1dhiCD5+ CD22−/− B cells but were not affected by the adoptive transfer of
CD1dloCD5− CD22−/− B cells (Fig. 3D). In fact, IFN-γ and TNF-α production were
virtually identical in macrophages from CD22 mAb-treated mice given CD1dhiCD5+
CD22−/− B cells and untreated control mice. Thus, the CD22 mAb-induced effects were
directly attributable to CD1dhiCD5+ B cell depletion.
A second set of adoptive transfer experiments were carried out to confirm that CD1dhiCD5+
B cell regulation of macrophage cytokine production was IL-10 dependent. Spleen
CD1dhiCD5+ and CD1dloCD5− B cells were purified from CD20−/− or IL-10−/−CD20−/−
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mice and adoptively transferred into wild type mice that were given CD20 mAb prior to
Listeria infection. Macrophage IFN-γ and TNF-α production were elevated similarly in
mice given either CD20 or CD22 mAb relative to macrophages isolated from control mAb-
treated Listeria-infected mice (Fig. 3C–E). However, the adoptive transfer of CD1dhiCD5+
B cells from CD20−/− mice reduced IFN-γ and TNF-α production in mice given CD20 mAb
by 43% and 60%, respectively, in comparison with CD1dloCD5− CD20−/− B cells (Fig. 3E).
Neither CD1dhiCD5+ nor CD1dloCD5− B cells from IL-10−/−CD20−/− mice affected IFN-γ
and TNF-α production by macrophages from CD20 mAb-treated mice (p=0.8). Thus,
endogenous B10 cells found within the CD1dhiCD5+ B cell subpopulation negatively
regulated macrophage cytokine production through IL-10-dependent pathways.
To verify that the ex vivo changes in macrophage IFN-γ secretion were durable,
macrophages purified from CD22 or control mAb-treated mice were cultured with LPS in
vitro. Following 4 h of LPS stimulation, macrophages from CD22 mAb-treated mice
secreted 62% (p=0.03) more IFN-γ than macrophages from control mAb-treated mice (Fig.
3F). After 24 h of culture without LPS stimulation, macrophages from CD22 mAb-treated
mice secreted 9.2-fold (p=0.01) more IFN-γ than macrophages from control mAb-treated
mice. After LPS stimulation, macrophages from CD22 mAb-treated mice secreted 30%
(p=0.03) more IFN-γ than macrophages from control mice. Nitric oxide production by
macrophages from CD22 mAb-treated mice was also 40% (p=0.04) higher than for
macrophages from control mAb-treated mice (Fig. 3G). Thereby, B10 cell negative
regulation of macrophage cytokine and nitric oxide production in vivo was persistent and
not reversed by ex vivo stimulation.
B10 cell depletion enhances macrophage phagocytosis of Listeria
Since macrophages play an important role in host defense during Listeria infections, the
ability of spleen CD11b+ macrophages from mice treated with either CD22 or control mAb
for 7 d were analyzed for their ability to phagocytose CFSE-labeled Listeria ex vivo in the
absence of extrinsic stimulation. Trypan blue was used to quench CFSE fluorescence from
cell surface-associated bacteria during flow cytometry analysis as described (51). Within
two hours, twice as many macrophages from CD22 mAb-treated mice (p=0.01) had
internalized bacteria when compared with macrophages from control mAb-treated mice
(Fig. 3H). Furthermore, macrophages from CD22 mAb-treated mice that had internalized
bacteria contained twice as many (p=0.01) bacteria as macrophages from control mAb-
treated mice. Thus, in vivo B10 cell depletion following CD22 mAb treatment significantly
enhanced the ex vivo phagocytic capacity of spleen macrophages.
B10 cell depletion reduces Ag-specific CD4+ T cell activation
The effect of CD22 mAb-induced B10 cell depletion on cellular immune responses was
quantified in wild type mice. CD22 mAb treatment did not significantly affect spleen CD4+
or CD8+ T cells in either uninfected or Listeria-infected mice (Fig. 4A). However, as shown
in Figure 1A, Listeria infection results in a transient reduction in CD4+ T cell numbers, and
this effect was blocked in mice given CD22 mAb but not control mAb. Therefore, B10 cell
depletion reduced the effect of Listeria infection on spleen CD4+ T cell frequencies.
The involvement of B10 cells during Ag-specific CD4+ T cell proliferation and function was
quantified in vivo using Thy1.1+ congenic mice that express an OVA-specific T cell
receptor transgene (40). CD4+ T cells purified from OT-II mice were CFSE-labeled and
adoptively transferred into CD22 or control mAb-treated wild type mice 1 d prior to Listeria
infection. Uninfected control mice were given PBS. Spleen Thy1.1+ OT-II T cell
proliferation was assessed 3 d later by measuring CFSE dilution. Relatively few OT-II T
cells from CD22 mAb-treated mice diluted CFSE (p<0.001, Fig. 4B), while OT-II T cells
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from infected mice given control mAb proliferated vigorously, with 75% of the T cells
diluting CFSE. Consistent with these results, half as many OT-II T cells isolated from CD22
mAb-treated mice were induced to produce IFN-γ when stimulated ex vivo with
OVA323-339 peptide in comparison with OT-II T cells from infected mice given control mAb
(p=0.005; Fig. 4C). CD4+ OT-II T cell production of IL-2 was equivalent in both CD22 and
control mAb-treated mice after infection. Thus, CD4+ T cell proliferation and cytokine
production were reduced in mice given CD22 mAb to deplete CD1dhiCD5+ B10 cells.
The effects of B10 cell depletion using CD22 mAb on Ag-specific CD8+ T cell proliferation
and function was also quantified in vivo using mice that express an OVA-specific T cell
receptor transgene (41). CD8+ T cells purified from OT-I mice were CFSE-labeled and
adoptively transferred into CD22 or control mAb-treated wild type mice 1 d prior to Listeria
infection, with spleen OT-I T cell proliferation assessed 3 d later. OT-I T cells proliferated
vigorously in infected mice given control or CD22 mAb, with >95% of the T cells diluting
CFSE (p=0.4; Fig. 4D). Ag-specific OT-I T cells from B10 cell-depleted or control-treated
mice also produced similar amounts of IFN-γ when stimulated ex vivo with OVA257-264
peptide (p=0.7; Fig. 4E). Thus, B10 cell depletion using CD22 mAb reduced Ag-specific
CD4+ but not CD8+ T cell proliferation and cytokine production in vivo.
B10 cell regulation is dependent on cognate interactions with CD4+ T cells
B10 cell regulation of T cell-mediated autoimmunity requires cognate interactions with
CD4+ T cells through MHC-class II and IL-21 dependent pathways to induce B10 cell
effector function and IL-10 production (32). Whether inflammatory signals or bacterial
products can induce regulatory B10 cell function independent of cognate T cell interactions
was therefore examined using CD19−/− mice infected with Listeria. Remarkably, the
adoptive transfer of wild type CD1dhiCD5+ B cells resulted in a subsequent 58-fold (p≤0.01)
increase in spleen bacteria loads following Listeria infection when compared to littermates
given PBS or CD1dloCD5− B cells (Fig. 5A). By contrast, the adoptive transfer of either
CD1dhiCD5+ or CD1dloCD5− B cells from MHC-II−/− mice, IL-21 receptor deficient
(IL-21R−/−) mice, or IL-10−/− mice did not significantly affect bacterial clearance. Thus,
IL-10, IL-21, and MHC-II expression were required to elicit regulatory B10 cell function
during innate immune responses to this bacterial pathogen.
DISCUSSION
The current studies demonstrate that Listeria manipulates early immune responses through a
strategy of immune evasion that involves preferential B10 cell expansion. Specifically,
spleen and lymph node B10 cell frequencies and numbers were acutely expanded by day 5
of infection (Fig. 1), with B10 cell production of IL-10 dramatically reducing bacteria
clearance (Fig. 2). Enhanced bacteria clearance in the absence of B10 cells or following
their in vivo depletion paralleled significantly improved macrophage phagocytosis of
bacteria (Fig. 3H) and their significantly increased production of IFN-γ, TNF-α and nitric
oxide ex vivo (Fig. 3C–G). Remarkably, B10 cell negative regulation of macrophage
cytokine production persisted even when the macrophages were restimulated ex vivo with
LPS (Fig. 3F). Enhanced bacteria clearance following B10 cell depletion using CD22 mAb
also significantly reduced Ag-specific CD4+ T cell expansion in response to Listeria
infection, but did not reduce Ag-specific CD8+ T cell expansion (Fig. 4). Thereby, B10 cell
expansion normally inhibits Listeria clearance in vivo by reducing macrophage activation,
which promotes bacteria persistence and the generation of foreign Ags that drive CD4+ T
cell expansion. B10 cell expansion thus shapes the qualitative and quantitative nature of
both innate and cellular immune responses during acute Listeria infections.
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In contrast with B10 cell expansion, B10 cell depletion significantly reduced spleen and
liver bacteria loads by 82–97% (Fig. 2, data not shown). This was demonstrated in three
ways. First, enhanced bacteria clearance was observed in CD19−/− mice that have
dramatically reduced numbers of B10 and B10pro cells, but otherwise have near normal B
cell numbers (Fig. 2C, ref. 13). Enhanced clearance of Listeria in the absence of B10 cells
was similar to the rapid clearance of Listeria in IL-10−/− mice (7). Second, Listeria clearance
was also dramatically accelerated in mice depleted of all mature B cells using a potent CD20
mAb (Fig. 2B). This result is consistent with enhanced bacteria clearance in B cell-deficient
μMT mice (58). Third, Listeria loads were significantly reduced in mice given a ligand-
blocking CD22 mAb that deleted most CD1dhiCD5+ B cells and 60–80% of spleen B10
cells (Fig. 2C, refs. 31, 57). However, the vast majority of spleen B cells remain intact after
CD22 mAb treatment. The elimination of CD1dhiCD5+ cells and B10 cells by select CD22
mAbs is not a consequence of the initiation of CD22 negative regulation or CD22 removal
from the cell surface during B cell Ag receptor signaling (unpublished observations), but
likely reflects the diversity of effects elicited by CD22 binding to appropriate in vivo ligands
(59). Remarkably, CD20 mAb and the ligand-blocking CD22 mAb used in these studies
deplete different percentages of B cells and utilize distinct mechanisms of action to deplete
B10 cells (43, 57), but their effects on bacteria clearance were identical to those observed in
CD19−/− mice without B10 cells. Moreover, B10 cell depletion by CD20 mAb and this
ligand-blocking CD22 mAb can also exacerbate cellular immunity and autoimmune disease
symptoms similarly (26, 31, 57). Thereby, B cell and particularly B10 cell manipulation has
significant effects on bacteria clearance and innate immune responses.
Listeria initially infects macrophages, with the subsequent elicitation of Ag-specific adaptive
immunity (60). Macrophages also serve as the primary in vivo mediators of Listeria
clearance (61). Thereby, enhanced Listeria clearance in the absence of B10 cells is likely to
result from the enhanced ability of macrophages from B10 cell-depleted mice to
phagocytose bacteria (Fig. 3H) and express cytokines (Fig. 3C–E) and nitric oxide (Fig. 3G)
in vivo. That B cell regulation of bacteria clearance by monocytes was B10 cell and IL-10-
dependent was confirmed by adoptive transfer experiments. First, the adoptive transfer of
wild type CD1dhiCD5+ B cells that are enriched for B10+B10pro cells (13, 32) reduced
Listeria clearance in CD19−/− mice to levels seen in wild type mice (Fig. 2E). By contrast,
the adoptive transfer of IL-10−/− CD1dhiCD5+ B cells or CD1dloCD5− B cells was without
effect. Second, the adoptive transfer of CD1dhiCD5+ B cells from CD22−/−CD154Tg mice,
where the majority of CD1dhiCD5+ B cells are B10 cells (31), normalized in vivo
macrophage TNF-α and IFN-γ production in CD22 mAb-treated mice, while
CD22−/−CD1dloCD5− B cells were without effect (Fig. 3D). Third, the adoptive transfer of
CD1dhiCD5+ B cells from CD20−/− mice normalized in vivo macrophage TNF-α and IFN-γ
production in CD20 mAb-treated mice, while CD20−/−CD1dhiCD5+ B cells were without
effect (Fig. 3E). Fourth, the adoptive transfer of CD1dhiCD5+ B cells from IL-10−/−CD20−/−
mice were unable to normalize in vivo macrophage TNF-α and IFN-γ production in CD20
mAb-treated mice. Consistent with these findings, small numbers of adoptively transferred
B10 cells inhibit macrophage activation through IL-10-dependent mechanisms and thereby
dramatically suppress antibody-mediated lymphoma depletion in vivo, as well as cytokine
production in vivo and in vitro (56). B10 cells also negatively regulate human macrophage
activation and phagocytic activity (33). Exogenous IL-10 also down-regulates macrophage
cytokine production in vitro, their generation of reactive oxygen intermediates, and cell
surface expression of MHC class II and other costimulatory molecules (62–64). B10 cell
inhibition of Listeria clearance is also consistent with the proposed role for B1 cell-derived
IL-10 in the regulation of B. hermsii clearance from the blood (15). These collective studies
thereby demonstrate that IL-10 production by the B10 cell subset has substantial regulatory
effects on macrophage function, including the clearance of Listeria and potentially other
pathogens.
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Acute expansion of the B10 cell subset after Listeria infection (Fig. 1B–D) was similar to
the rapid increase in B10 cells that occurs during inflammation (13, 20, 26, 56) and the
regulatory B cell increases observed with other inflammatory conditions (15–18). By
contrast, there was only modest expansion of the FoxP3+CD4+ regulatory T cell subset by
day 5 following infection (Fig. 1H). B10 cell expansion at early time-points in the absence
of regulatory T cell expansion also occurs during experimental autoimmune
encephalomyelitis in mice (26). Thereby, acute Listeria infection may preferentially expand
B10 cells but not regulatory T cells to manipulate IL-10 levels and increase bacterial loads
that may be normally required to drive early Treg and CD4+ T cell expansion. Rapid Listeria
clearance in the absence of B10 cells following CD22 mAb-treatment may thereby limit the
availability of foreign Ags and explain the dramatic reductions in CD4+ T cell proliferation
and cytokine production in the current studies (Fig. 4B–C). Alternatively, the absence of
B10 cells may facilitate the rapid development of potent CD8+ effector T cells that facilitate
bacteria clearance. Reduced bacteria loads with augmented T cell responses have been
observed in μMT mice after Listeria infection (65). Acute Listeria-driven expansion of the
B10 cell subset thereby accelerates the accumulation of stimulatory foreign Ags that
determine the magnitude of CD4+ but not CD8+ T cell proliferation and cytokine
production.
B10 cell function appears Ag-specific in models of inflammation, and Ag receptor
specificity and signaling are critical components for B10 cell function in vivo (30, 32). For
example, B10 cells fail to develop in CD19−/− mice where B cell Ag receptor signaling is
muted (Fig. 2A). While B cell Ag receptor signaling appears to direct B10 cell development,
cognate interactions with Ag-specific T cells producing IL-21 appear critical for the
development of IL-10-producing B10 effector cells (32), which may then negatively
regulate cognate CD4+ T cell partners (Fig. 5B). B10 cell expansion may thereby normally
limit Ag-specific CD4+ T cell proliferation and cytokine production during acute Listeria
infections, or may alternatively reshape the repertoire of CD4+ T cells that expand in
response to infection. Consistent with this, regulatory B10 cell inhibition of bacteria
clearance required that B10 cells express IL-10, MHC class II molecules, and CD21-R (Fig.
5A), arguing that B10 cells require cognate interactions with CD4+ T cells to induce their
regulatory effector functions during infections (Fig. 5B) as occurs during T cell-mediated
autoimmunity (32). Given this, macrophage function is likely to be regulated downstream of
B10 cell interactions with CD4+ T cells. Under these conditions, B10 cell negative
regulation of monocyte function would remain Ag-specific and may only affect
macrophages within the local microenvironment of ongoing immune responses.
In addition to the current studies with B cells, IL-10 produced by other immune cells is
known to modulate host immune responses to diverse pathogens including Listeria,
Bordetella pertussis, lymphocytic choriomeningitis virus, and vaccinia virus (6, 9, 11, 66).
Gram-negative bacteria also induce B cells to express IL-10 through a MyD88-dependent
pathway, which inhibits immunity (14). It is therefore possible that pathogens also utilize
TLR-signaling pathways to induce B10 cell IL-10 production. Consistent with this,
inflammatory signals and bacterial products are potent stimulators of B10 cell maturation
and IL-10 production (30). However, B10 cells develop normally in both MyD88-deficient
and pathogen-deficient mice, and B10 cell function remains Ag-specific in models of
inflammation, which suggests that Ag receptor specificity and signaling are also critical
components for B10 cell function in vivo (30). Given the negative regulatory functions of
B10 cells and their capacity to modulate both innate and adaptive immune responses, it is
likely that pathogens will utilize multiple diverse mechanisms to manipulate B10 cell
function and biology to modulate immune responses to their advantage. Alterations in the
numbers and/or proportions of B10 cells during acute infections may thus have major
ramifications for quantitatively and qualitatively programming subsequent innate and
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cellular immune responses that might be manipulated for the development of vaccines to a
variety of pathogens.
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Figure 1. B10 cells expand following Listeria infection
Wild type mice were given PBS or infected with 8×105 cfu of Listeria-OVA on d 0. (A)
Spleen B and T cell numbers after Listeria infection. At the indicated times post-infection,
CD19+ B cell and CD4+ T cell frequencies and numbers were determined by
immunofluorescence staining with flow cytometry analysis. Data from PBS-treated control
mice were unchanged across all time points (d 3, 5, and 8 post-infection) and were therefore
pooled. Values represent mean (± SEM, n=3–6/group) cell frequencies or numbers. (B) B10
cells expand after Listeria infection. At the indicated times post-infection, spleen and lymph
node lymphocytes were stimulated ex vivo with LPS, PMA, ionomycin, and monensin
(LPIM) for 5 h and stained for cell surface CD19 and intracellular IL-10. Representative
histograms show IL-10 expression by viable and single spleen CD19+ B cells. Cells from
infected mice that were cultured with monensin alone served as negative staining controls.
Numbers indicate the frequencies of cells within the indicated gates. Data from PBS-treated
mice were unchanged across all time points (d 3, 5, and 8 post-infection) and were therefore
pooled. Values in the bar graphs represent mean (± SEM, n=10) frequencies or numbers of
IL-10+ B cells. (C) The spleen CD1dhiCD5+CD19+ B cell subset expands after Listeria
infection. At the indicated times post-infection, CD1dloCD5+CD19+ and
CD1dhiCD5+CD19+ B cell subset frequencies and numbers were determined. The data are
presented as in (B, n=7). (D) B cell GFP expression in IL-10 reporter Tiger mice. Five d
after infection, splenocytes were stimulated ex vivo with LPIM for 5 h before staining for
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cell surface CD19 and evaluating CD19+ B cell intracellular GFP expression by flow
cytometry. Numbers indicate cell frequencies within the indicated gates. Values in bar
graphs represent mean (± SEM, n=5) frequencies or numbers of CD19+GFP+ B cells 5 d
post-infection. (E) Spleen and lymph node B10+B10pro cell frequencies and numbers
following Listeria infection. B10+B10pro cells were enumerated after 48 h of stimulation
with CD40 mAb, with LPIM added during the final 5 h of culture. Representative
histograms show IL-10 expression by viable and single spleen CD19+ B cells, with bar
graphs as in (B, n=10). (F–G) Listeria infection enhances B10 cell IL-10 production.
Purified spleen (F) CD19+ B cells or (G) CD1dhiCD5+ and CD1dloCD5− B cell subsets were
isolated from mice 5 d after infection and cultured for 72 h with or without LPS. Culture
supernatant fluid IL-10 concentrations were measured by ELISA. Bar graphs indicate mean
IL-10 concentrations (± SEM, n=3). (H) Treg cells do not expand following Listeria
infection. Histograms show representative FoxP3 and CD25 expression by splenic CD4+ T
cells 5 d post-infection. Values in the bar graphs represent mean (± SEM, n=5) frequencies
or numbers of CD25+FoxP3+ CD4+ Treg cells, activated CD25+FoxP3− CD4+ T cells
(Tact), or B10 cells. (A–H) Significant differences between sample means for mice given
PBS or infected are indicated: *; p<0.05; **; p <0.01.
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Figure 2. B10 cells inhibit Listeria clearance
Spleen B10 cell numbers in (A) CD19−/− mice, (B) mice given either CD20 or isotype
control mAb on d −7 or (C) mice given CD22 or isotype control mAb on d −7 and −1 before
Listeria infection or PBS treatment on d 0. Five d later, splenocytes were stimulated ex vivo
with LPIM for 5 h before staining for cell surface (A) B220, (B) CD19, or (C) CD19, CD1d,
and CD5, and intracellular IL-10 expression. (D) CD19-deficiency, total B cell depletion,
and CD22 mAb treatment enhance bacterial clearance. Mice treated as in (A–C) were
infected with Listeria on day 0, and the number of bacteria present within their spleens was
quantified 3 d (and 5 d, for CD22 mAb) later. Values represent mean (± SEM, n=8) bacterial
loads in each set of mice. (E) B10 cells inhibit bacterial clearance through IL-10-dependent
mechanisms. Representative fractionation of purified spleen CD19+ B cells from wild type
or IL-10−/− mice into CD1dhiCD5+ (B10 cell enriched) or CD1dloCD5− B cell populations
by cell sorting. The cells were then adoptively transferred into CD19−/− mice. One d later,
the recipient mice were treated with PBS or infected with Listeria. Bar graphs represent
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mean (± SEM, n=7) spleen bacterial loads 3 d later. (A–E) Significant differences between
means are indicated: *; p<0.05; **; p <0.01.
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Figure 3. B10 cell depletion enhances macrophage cytokine production and phagocytosis
In all experiments, wild type mice were given CD22 or isotype control mAb on d −7 and −1
and infected with Listeria on d 0. (A) CD22 mAb-treatment does not alter macrophage or
neutrophil numbers in vivo. Frequencies and numbers of viable spleen CD11b+Ly6C+
macrophages and CD11b+Ly6G+ neutrophils were quantified ex vivo 1 d post-infection with
Listeria by immunofluorescence staining with flow cytometry analysis. Values represent
mean (± SEM, n=3) cell frequencies and numbers among spleen mononuclear cells. (B)
CD22 mAb-treatment does not induce macrophage activation in vivo. Spleen
F4/80+CD11b+ macrophage CD80 and CD86 mean fluorescence staining intensities (MFI)
were quantified ex vivo 1 d post-infection with Listeria by immunofluorescence staining
with flow cytometry analysis. Values represent mean (± SEM, n=3) MFI values with isotype
control mAb background staining subtracted. (C) CD22 mAb-treatment enhances
macrophage cytokine production. Representative histograms show intracellular IFN-γ and
TNF-α expression by viable, single F4/80+CD11b+ spleen macrophages directly ex vivo 1 d
post-infection with Listeria as assessed by immunofluorescence staining. Background
staining was determined using isotype-matched control antibodies. (D) Adoptively
transferred CD1dhiCD5+ B10 cells inhibit macrophage cytokine production in CD22 mAb-
treated mice. In parallel with the experiments in (C), mice were given either control or CD22
mAb. Subsequently, the mice were given purified spleen CD1dhiCD5+ or
CD1dloCD5−CD19+ B cells from CD22−/−CD154Tg mice. One day later, the recipient mice
were infected with Listeria, with spleen macrophage IFN-γ and TNF-α expression
quantified as in (C). (C,D) Bar graphs show mean (± SEM, n=5) frequencies of cytokine
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expressing cells within the indicated gates. (E) Spleen CD1dhiCD5+ B cells inhibit
macrophage cytokine production through IL-10 production. Wild type mice were given
control or CD20 mAb as in figure 2B–C. Subsequently, the mice were given either purified
spleen CD1dhiCD5+ or CD1dloCD5− CD19+ B cells from CD20−/− or IL-10−/−CD20−/−
mice. One day later, the recipient mice were infected with Listeria, with spleen macrophage
IFN-γ and TNF-α expression assessed as in (C). (F–G) CD22 mAb-treatment in vivo
regulates spleen macrophage cytokine and nitric oxide production ex vivo. Adherent
macrophages isolated from CD22 or control mAb-treated Listeria-infected mice generated
as in (C) were stimulated with LPS. Mean (± SEM) supernatant fluid (F) IFN-γ (4 or 24 h
cultures, n=6) or (G) nitrate (24 h culture, n=6) concentrations were quantified by ELISA.
(H) CD22 mAb-treatment enhances macrophage phagocytosis of CFSE-labeled Listeria.
Mice were treated with CD22 or isotype-matched control mAb on d −7 and −1. Spleen
CD11b+ macrophages were isolated on d 0 and cultured with CFSE-labeled Listeria for 2 h.
The histogram shows representative intracellular CFSE fluorescence of macrophages from
CD22 or control mAb-treated mice cultured without (No Lm) or with CFSE-labeled Listeria.
The horizontal line indicates the flow cytometry gate used for quantifying CFSE-positive
cells. Bar graphs represent mean (± SEM, n=8) frequencies of CFSE+ macrophages or mean
fluorescent intensities (MFI) of CD11b+CFSE+ cells. (A–H) Significant differences between
the sample means are indicated: *; p<0.05; **; p <0.01.
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Figure 4. B10 cells regulate Ag-specific CD4+ T cell activation
Wild type mice were given CD22 or control mAb on day −7 and −1 and were infected with
Listeria-OVA on day 0. (A) CD22 mAb treatment normalizes spleen CD4+ T cell numbers
following Listeria infection. Values represent mean (± SEM, n=6) frequencies and numbers
of total spleen CD4+ and CD8+ T cells 5 d post-infection or treatment with PBS. (B) CD22
mAb-treatment reduces Ag-specific spleen CD4+ T cell proliferation. CD22 or control mAb-
treated and infected mice received CFSE-labeled spleen Thy1.1+OT-II CD4+ T cells on d
−1. The in vivo proliferation of adoptively transferred CFSE-labeled Thy1.1+OT-II T cells
was assessed by CFSE dilution 3 d following infection. Representative histograms
demonstrate CFSE staining for uninfected mice (PBS) versus infected mice treated with
control or CD22 mAb, with the percentages of dividing cells indicated. Bar graph values
represent mean (± SEM, n=6) frequencies of spleen Thy1.1+OT-II T cells with diluted
Horikawa et al. Page 22










CFSE in infected mice. (C) CD22 mAb-treatment reduces Ag-specific CD4+ T cell cytokine
production. Splenocytes from control or CD22 mAb treated mice given Thy1.1+ OT-II T
cells as in (B) were harvested 3 d post-Listeria infection and stimulated ex vivo with media
alone or OVA323-339 peptide for 4 h in the presence of brefeldin A. IFN-γ, IL-2, and TNF-α
production were assessed by intracellular staining with flow cytometry analysis.
Representative dot plots show relative frequencies of cytokine expressing spleen Thy1.1+ T
cells within the indicated gates. Bar graphs represent mean (± SEM, n=6) frequencies of
Thy1.1+ OT-II T cells expressing each cytokine. (D) B10 cell depletion does not reduce Ag-
specific spleen CD8+ T cell proliferation. CD22 or control mAb-treated and infected mice
received CFSE-labeled spleen Thy1.1+ OT-I CD8+ T cells on d −1. The in vivo proliferation
of adoptively transferred CFSE-labeled spleen Thy1.1+ OT-I T cells was assessed as in (B;
n=6). (E) B10 cell depletion does not reduce spleen Ag-specific CD8+ T cell cytokine
production. Cytokine production by adoptively transferred Thy1.1+ OT-I T cells was
assessed as in (C) using OVA257-264 peptide (n=4). (A–E) Significant differences between
the indicated sample means among control mAb and CD22 mAb treated mice are indicated:
*; p<0.05; **; p <0.01.
Horikawa et al. Page 23











B10 cell regulation of innate immune responses to Listeria requires cognate interactions
with CD4+ T cells. (A) B10 cell MHC class II, IL-10, and IL-21R expression are required
for regulation of innate immune responses. CD19−/− mice were either given PBS or purified
spleen CD1dhiCD5+ or CD1dloCD5− B cells from naïve wild type (WT), MHC-II−/−,
IL-10−/−, or IL-21R−/− mice 1 day before Listeria infection. Values represent mean (±SEM)
spleen bacterial counts from ≥4 mice in each group 3 days after infection. Significant
differences between the indicated sample means are shown: **, p<0.01. (B) Model for
pathogen (Ag)-specific B10 cell function. B cells capture Ags that trigger appropriate BCR
signals (step 1) and promote IL-10-competent B10pro cell development. During immune
responses (step 2), B10pro cells present peptides to Ag-specific CD4+ T cells through
cognate interactions that induce T cell activation and CD40/CD154 interactions. Activated T
cells may produce IL-21 locally, which binds to proximal B10 cell IL-21R (step 3). IL-21R
signals induce B10 cell IL-10 production and effector function (B10eff, step 4), which may
negatively regulate Ag-specific T cell function (step 5). Indirectly, B10 effector cell
production of IL-10 in the local environment negatively regulates macrophage activation
and effector function.
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